Search

Your search keyword '"McGuire WP 3rd"' showing total 24 results

Search Constraints

Start Over You searched for: Author "McGuire WP 3rd" Remove constraint Author: "McGuire WP 3rd"
24 results on '"McGuire WP 3rd"'

Search Results

1. Phase I Study of Sorafenib and Vorinostat in Advanced Hepatocellular Carcinoma.

2. A phase II study of irofulven in women with recurrent and heavily pretreated ovarian cancer.

4. Primary ovarian cancer chemotherapy: current standards of care.

5. Current status of taxane and platinum-based chemotherapy in ovarian cancer.

6. Progress in the management of gynecologic cancer: consensus summary statement.

7. Phase I trial of escalating doses of paclitaxel combined with fixed doses of cisplatin and doxorubicin in advanced endometrial cancer and other gynecologic malignancies: a Gynecologic Oncology Group study.

8. Phase I trial of paclitaxel and etoposide for recurrent ovarian carcinoma: a Gynecologic Oncology Group Study.

9. High-dose chemotherapeutic approaches to ovarian cancer management.

10. Camptothecin analogues/cisplatin: an effective treatment of advanced bladder cancer in a preclinical in vivo model system.

11. Phase I trial and pharmacologic trial of sequences of paclitaxel and topotecan in previously treated ovarian epithelial malignancies: a Gynecologic Oncology Group study.

12. Carboplatin and paclitaxel in ovarian carcinoma: a phase I study of the Gynecologic Oncology Group.

13. Primary chemotherapy in epithelial ovarian cancer.

14. Salvage therapy in epithelial ovarian cancer.

15. Treatment of advanced medullary thyroid carcinoma with a combination of cyclophosphamide, vincristine, and dacarbazine.

16. Paclitaxel (Taxol) therapy in ovarian carcinoma.

17. Taxol in epithelial ovarian cancer.

18. Synchronous mature teratomas of the ovary and liver: a case presenting 11 years following chemotherapy for immature teratoma.

20. Phase II study of N-methylformamide (N-MF) (NSC 3051) in patients with advanced epithelial ovarian cancer. A Gynecologic Oncology Group study.

21. Phase II study of N-methylformamide (N-MF) (NSC 3051) in patients with advanced squamous cancer of the cervix. A Gynecologic Oncology Group study.

22. Immediate versus postponed combination chemotherapy (CAMP) for unresectable non-small cell lung cancer: a randomized trial.

23. Adjuvant systemic therapy of lung cancer.

24. A randomized comparative trial of carboplatin and iproplatin in advanced squamous carcinoma of the uterine cervix: a Gynecologic Oncology Group study.

Catalog

Books, media, physical & digital resources